Nanocarbons with different dimensions (eg, 0D fullerenes and carbon nanodots, 1D carbon
nanotubes and graphene nanoribbons, 2D graphene and graphene oxides, and 3D …

Cancer is rapidly becoming the top killer in the world. Most of the FDA approved anticancer
drugs are organic molecules, while metallodrugs are very scarce. The advent of the first …

Precise nanomedicine has been extensively explored for efficient cancer imaging and
targeted cancer therapy, as evidenced by a few breakthroughs in their preclinical and …

Nanocarriers have received special attention in biomedicine for the treatment of various
diseases, especially cancer, as one of the leading causes of death worldwide. Nanocarriers …

Carbon nanomaterials are a class of low-dimensional materials that have aroused a great
deal of interest in the past 30 years since the spectacular debut of fullerene, the first member …

The design and use of materials in the nanoscale size range for addressing medical and
health-related issues continues to receive increasing interest. Research in nanomedicine …

In 2004, the US Food and Drug Administration (FDA) released an important report entitled
“Innovation/Stagnation: Challenge and Opportunity on the Critical Path to New Medical …

The fast advances of theranostic nanomedicine enable the rational design and construction
of diverse functional nanoplatforms for versatile biomedical applications, among which gas …

One of the major components in the development of nanomedicines is the choice of the right
biomaterial, which notably determines the subsequent biological responses. The popularity …

One of the attractive properties of the hollow carbon clusters, known as fullerenes, is the
possibility to use them as robust containers for other species. Although an IUPAC …